Skip to main content

BBVA vs Roche: Founders, CEOs and History

BBVA was founded in 1857 by Bilbao Board of Trade and is led by Onur Genç. Roche was founded in 1896 by Fritz Hoffmann-La Roche and is led by Thomas Schinecker.

Company facts

BBVA

Founded
1857
Headquarters
Madrid, Spain
Current CEO
Onur Genç
Employees
127,174

Roche

Founded
1896
Headquarters
Basel, Switzerland
Current CEO
Thomas Schinecker
Employees
112,774

Founders

BBVA

  • Bilbao Board of Trade

    No individual is recorded as the founder of BBVA's oldest institution. Banco de Bilbao was created in 1857 after the Bilbao Board of Trade, the body representing the port city's merchants, promoted a bank that could issue banknotes and discount commercial bill…

BBVA founders in full

Roche

  • Fritz Hoffmann-La Roche

    Fritz Hoffmann-La Roche (1868-1920) founded F. Hoffmann-La Roche & Co. in Basel on 1 October 1896, at age 28.

Roche founders in full

CEOs and their tenures

BBVA

  1. Pedro Luis Uriarte1999–2001

    Chief Executive Officer

    Chief executive and vice chairman of BBV from September 1994 and of the merged BBVA until he retired at the end of 2001.

    Source
  2. Francisco Gonzalez2000–2018

    Executive Chairman

    Chaired Argentaria before its 1999 merger with BBV and then BBVA until December 2018, 22 years at the head of the group in total. He drove the bank's technology rebuild and the 2007 purchase of Compass Bancshares in the United States.

    Source
  3. Jose Ignacio Goirigolzarri2001–2009

    Chief Executive Officer

    Chief executive of BBVA from 2001 to 2009, the period that covered the USD4.1 billion buyout of the rest of BBVA Bancomer in 2004 and the USD9.6 billion purchase of Compass Bancshares in 2007. He later chaired Bankia and CaixaBank.

    Source
  4. Angel Cano2009–2015

    Chief Executive Officer

    Appointed chief executive in September 2009, replacing Jose Ignacio Goirigolzarri.

    Source
  5. Carlos Torres Vila2015–2018

    Chief Executive Officer

    Chief executive from May 2015 until December 31, 2018, when he became executive chairman and Onur Genc took over as CEO. He had joined BBVA in 2008 to run strategy and corporate development and led digital banking from 2014.

    Source
  6. Onur Genc2018–present

    Chief Executive Officer

    Took over as CEO on December 31, 2018, the day Carlos Torres Vila became executive chairman.

    Source
BBVA CEO history in full

Roche

  1. Severin Schwan2008–2023

    Chief Executive Officer

    Serving as CEO from 2008 to 2023, he cemented Roche's absolute dominance in global oncology and highly advanced diagnostics before moving to Chairman of the Board.

    Source
  2. Thomas Schinecker2023–present

    Chief Executive Officer

    Under Schinecker, Roche returned to growth after the COVID testing decline: 2025 sales rose 7% at constant rates to ~$73.8 billion (CHF 61.5 billion) and 12 late-stage studies read out positively that year.

    Source
Roche CEO history in full

Timeline: BBVA and Roche side by side

  1. 1857BBVA

    Banco de Bilbao is created

    Bilbao's Board of Trade promotes the creation of Banco de Bilbao as a bank of issue and discount for the city's merchants. It is the oldest institution in BBVA's corporate line.

  2. 1896Roche

    F. Hoffmann-La Roche Founded in Basel

    Fritz Hoffmann-La Roche founds the enterprise in Basel, Switzerland, pioneering mass-manufactured, chemically standardized prescription pharmaceuticals.

  3. 1898Roche

    Commercial Breakthrough with Sirolin

    Roche launches non-prescription cough syrup Sirolin, achieving widespread international distribution and financing early clinical laboratories.

  4. 1901BBVA

    Banco de Vizcaya is founded

    Banco de Vizcaya is founded in Bilbao and grows alongside Banco de Bilbao as the second large Basque bank, financing regional industry.

  5. 1934Roche

    First Industrial Synthesis of Vitamin C

    Roche becomes the first company to mass-produce synthetic Vitamin C (Redoxon) at industrial scale, anchoring decades of high-margin global cash flow.

  6. 1963Roche

    Launch of Valium (Diazepam)

    Roche introduces Valium, which becomes the world's most widely prescribed psychotropic medication and establishes global pharmaceutical leadership.

  7. 1968Roche

    Establishment of Roche Diagnostics

    Roche launches its dedicated diagnostic division, laying the foundation to become the world's preeminent in-vitro diagnostics (IVD) provider.

  8. 1988BBVA

    Banco de Bilbao and Banco de Vizcaya merge

    The two Basque rivals merge to form Banco Bilbao Vizcaya (BBV), one of the largest banks in Spain ahead of the European single market.

  9. 1999BBVA

    BBV merges with Argentaria to create BBVA

    BBV merges with Argentaria, the group Spain had assembled from state-owned lenders such as Banco Exterior, Banco Hipotecario and Caja Postal, forming Banco Bilbao Vizcaya Argentaria.

  10. 2000BBVA

    BBVA takes control of Bancomer in Mexico

    BBVA capitalizes Bancomer with USD1.4 billion and merges it with BBV-Probursa to create Grupo Financiero BBVA Bancomer, the largest bank in Mexico.

  11. 2004BBVA

    BBVA bids for the rest of BBVA Bancomer

    BBVA offers USD4.1 billion in cash for the roughly 41 percent of BBVA Bancomer held by minority investors, ending with about 99 percent of the Mexican group.

  12. 2007BBVA

    Compass Bancshares purchase builds a US franchise

    BBVA buys Compass Bancshares of Birmingham, Alabama for USD9.6 billion, creating a Sunbelt retail bank that later traded as BBVA Compass and BBVA USA.

  13. 2008Roche

    Severin Schwan becomes CEO

    Severin Schwan became CEO of F. Hoffmann-La Roche in 2008. Led Roche for 14 years; handed over to Thomas Schinecker in March 2023 and became chairman.

  14. 2009Roche

    Full Acquisition of Genentech for $46.8 Billion

    Roche completes its historic $46.8 billion buyout of American biotechnology pioneer Genentech, securing market leadership in oncology biologics.

  15. 2010BBVA

    BBVA agrees to buy 24.9 percent of Garanti

    BBVA agrees to pay ~$4.74 billion (EUR4.195 billion), about USD5.84 billion, for 24.9 percent of Turkiye Garanti Bankasi, funded with a rights issue of about $5.65 billion (EUR5 billion).

  16. 2014BBVA

    BBVA wins the auction for Catalunya Banc

    BBVA bids ~$1.34 billion (EUR1.187 billion) for Catalunya Banc, with 1.5 million customers and ~$71.2 billion (EUR63 billion) of assets, in the auction run by Spain's bank restructuring fund. The deal closed in 2015.

  17. 2018BBVA

    Onur Genc is named CEO

    BBVA's board designates Onur Genc as chief executive from December 31, 2018, the date Carlos Torres Vila replaces Francisco Gonzalez as executive chairman.

  18. 2018Roche

    Foundation Medicine & Flatiron Health Acquisitions

    Roche acquires Foundation Medicine and Flatiron Health, integrating real-world oncology data analytics and genomic profiling into personalized healthcare.

  19. 2019BBVA

    BBVA unifies its brand worldwide

    The group drops local names such as BBVA Bancomer, BBVA Francés, BBVA Continental and BBVA Compass and operates as BBVA in every market.

  20. 2021BBVA

    BBVA closes the transfer of BBVA USA to PNC

    BBVA completes the transfer of BBVA USA Bancshares to PNC Financial Services on June 1, 2021, receiving about USD11.5 billion, equivalent to ~$10.8 billion (EUR9.6 billion), in cash.

  21. 2022BBVA

    Tender offer lifts the Garanti stake to 85.97 percent

    A tender offer at 15 Turkish lira per share closes in May 2022 and raises BBVA's holding in Garanti BBVA to 85.97 percent.

  22. 2023Roche

    Acquired Telavant

    F. Hoffmann-La Roche acquired Telavant for $7.1 billion. Roche paid $7.1 billion upfront for Telavant to gain US and Japan rights to the anti-TL1A antibody RVT-3101 (afimkibart) for inflammatory bowel disease.

  23. 2025BBVA

    The offer for Banco Sabadell lapses

    Shareholders representing 25.47 percent of Sabadell's voting rights accept BBVA's all-share offer, short of the minimum BBVA required, and the bid lapses on October 16, 2025.

  24. 2025BBVA

    Record net attributable profit of ~$11.9B (EUR10.511B)

    BBVA reports gross income of ~$41.7B (EUR36.931B) and net attributable profit of ~$11.9B (EUR10.511B) for 2025, with ROTE of 19.3 percent and an efficiency ratio of 38.8 percent.

  25. 2025Roche

    Group Sales Reach CHF 61.5 Billion

    Under CEO Thomas Schinecker, Roche delivers group sales of ~$73.8 billion (CHF 61.5 billion), driven by ~$57.2B (CHF 47.7B) in Pharmaceuticals and ~$16.6B (CHF 13.8B) in Diagnostics.

  26. 2026BBVA

    BBVA is ordered to stand trial in the Villarejo case

    Spain's National Court orders BBVA, former chairman Francisco Gonzalez and 14 other defendants to stand trial over work commissioned from former police commissioner Jose Manuel Villarejo between 2004 and 2016.

Acquisitions

BBVA

  • Turkiye Garanti Bankasi tender offer (Turkey)2022Undisclosed
  • Catalunya Banc (Spain)2014Undisclosed
  • Turkiye Garanti Bankasi 24.9 percent stake (Turkey)2010$5.8B
  • Compass Bancshares (United States)2007$9.6B
  • BBVA Bancomer minority shares (Mexico)2004$4.1B
  • Grupo Financiero Bancomer (Mexico)2000$1.4B
All BBVA acquisitions

Roche

  • PathAI2026$1.1B
  • 89bio2025$3.5B
  • Telavant2023$7.1B
  • Carmot Therapeutics2023$2.7B
  • Foundation Medicine2018$2.4B
  • ForSight VISION42017Undisclosed
All Roche acquisitions

Questions about BBVA vs Roche

Who is the CEO of Banco Bilbao Vizcaya Argentaria, S.A. and F. Hoffmann-La Roche AG?

Banco Bilbao Vizcaya Argentaria, S.A. is led by Onur Genç and F. Hoffmann-La Roche AG is led by Thomas Schinecker. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.

When was Banco Bilbao Vizcaya Argentaria, S.A. founded vs F. Hoffmann-La Roche AG?

Banco Bilbao Vizcaya Argentaria, S.A. was founded in 1857 — 39 years before F. Hoffmann-La Roche AG, which was founded in 1896. Banco Bilbao Vizcaya Argentaria, S.A.'s longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger F. Hoffmann-La Roche AG.

How many employees does Banco Bilbao Vizcaya Argentaria, S.A. have compared to F. Hoffmann-La Roche AG?

Banco Bilbao Vizcaya Argentaria, S.A. employs approximately 127,174 people, while F. Hoffmann-La Roche AG employs approximately 112,774. Banco Bilbao Vizcaya Argentaria, S.A. has the larger workforce at 127,174 employees, compared to F. Hoffmann-La Roche AG's 112,774. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).

Where are Banco Bilbao Vizcaya Argentaria, S.A. and F. Hoffmann-La Roche AG headquartered?

Banco Bilbao Vizcaya Argentaria, S.A. is headquartered in Spain and F. Hoffmann-La Roche AG is headquartered in Switzerland. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.

Who founded Banco Bilbao Vizcaya Argentaria, S.A. and F. Hoffmann-La Roche AG?

Banco Bilbao Vizcaya Argentaria, S.A. was founded by Bilbao Board of Trade. F. Hoffmann-La Roche AG was founded by Fritz Hoffmann-La Roche.

Which company has a longer operating history — Banco Bilbao Vizcaya Argentaria, S.A. or F. Hoffmann-La Roche AG?

Banco Bilbao Vizcaya Argentaria, S.A. has been operating for approximately 169 years, making it the more established of the two companies. F. Hoffmann-La Roche AG has been in operation for around 130 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.

Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the BBVA vs Roche overview

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.